Risk Stratification for Invasive Fungal Infections in Patients with Hematological Malignancies: SEIFEM recommendations
Invasive fungal infections (IFIs) are an important cause of morbidity and mortality in immunocompromised patients. Patients with hematological malignancies undergoing conventional chemotherapy, autologous or allogeneic hematopoietic stem cell transplantation are considered at high risk, and Aspergillus spp. represents the most frequently isolated micro-organisms. In the last years, attention has also been focused on other rare molds (e.g., Zygomycetes, Fusarium spp.) responsible for devastating clinical manifestations.
Source: Blood Reviews - Category: Hematology Authors: Livio Pagano, Alessandro Busca, Anna Candoni, Chiara Cattaneo, Simone Cesaro, Rosa Fanci, Gianpaolo Nadali, Leonardo Potenza, Domenico Russo, Mario Tumbarello, Annamaria Nosari, Franco Aversa, on behalf of SEIFEM (Sorveglianza Epidemiologica Infezioni Fun Tags: REVIEW Source Type: research
More News: Aspergillus | Cancer & Oncology | Chemotherapy | Epidemiology | Fungal Infections | Hematology | Stem Cell Therapy | Stem Cells | Transplants